TScan Therapeutics Stock (NASDAQ:TCRX), Quotes and News Summary

Q: What sector and industry does TScan Therapeutics (TCRX) operate in?

TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TScan Therapeutics Stock (NASDAQ: TCRX) stock price, news, charts, stock research, profile.

Open	$7.260
Close	$7.290
Volume / Avg.	107.354K / 194.761K
Day Range	7.035 - 7.457
52 Wk Range	1.620 - 9.000
Market Cap	$392.771M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	54
Short Interest	0.65%
Days to Cover	1

Recent News

Worthington Steel Posts Upbeat Results, Joins Summit Midstream Partners, FedEx And Other Big Stocks Moving Higher On Friday

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.

Avi Kapoor

Around $10M Bet On This Real Estate Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones closed higher by around 10 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Tscan Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy TScan Therapeutics (TCRX) stock?

You can purchase shares of TScan Therapeutics (NASDAQ: TCRX) through any online brokerage.

View our list of the best stock brokerages.

Who are TScan Therapeutics's (TCRX) competitors?

Other companies in TScan Therapeutics’s space includes: Skye Bioscience (NASDAQ:SKYE), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and Replimune Group (NASDAQ:REPL).

What is the target price for TScan Therapeutics (TCRX) stock?

The latest price target for TScan Therapeutics (NASDAQ: TCRX) was reported by Wedbush on Tuesday, April 23, 2024. The analyst firm set a price target for 10.00 expecting TCRX to rise to within 12 months (a possible 34.59% upside). 8 analyst firms have reported ratings in the last year.

Current Stock Price for TScan Therapeutics (TCRX)?

The stock price for TScan Therapeutics (NASDAQ: TCRX) is $7.43 last updated April 25, 2024 at 4:51 PM EDT.

Does TScan Therapeutics (TCRX) pay a dividend?

A quarterly cash dividend of $0.42 per share of Class A Common Stock. The quarterly cash dividend was payable on June 30, 2018 to stockholders of record on June 14, 2018.

When is TScan Therapeutics (NASDAQ:TCRX) reporting earnings?

TScan Therapeutics’s Q1 earnings are confirmed for Wednesday, May 8, 2024.

Is TScan Therapeutics (TCRX) going to split?

There is no upcoming split for TScan Therapeutics.

What sector and industry does TScan Therapeutics (TCRX) operate in?

TScan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-